Profile
Tatsuyoshi Hirano served as President & Representative Director at UMN Pharma, Inc. and UNIGEN Inc. He also worked as Principal at Shin-Etsu Chemical Co., Ltd.
and as Chief Financial Officer & Executive Vice President at Toys "R" Us-Japan Ltd.
Hirano holds a graduate degree from The Johns Hopkins University and an undergraduate degree from the University of Hitotsubashi.
Former positions of Tatsuyoshi Hirano
Companies | Position | End |
---|---|---|
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | President | - |
Toys "R" Us-Japan Ltd.
Toys "R" Us-Japan Ltd. Specialty StoresRetail Trade Toys "R" Us-Japan Ltd. operates a chain of toy and juvenile products retail stores. Its products include educational toys, dolls, plush toys and character toys, video games, bicycles, sporting goods, stationery, baby clothing, shoes, strollers, car seats, food and formula. The company was founded on November 21, 1989 and is headquartered in Kawasaki, Japan. | Director of Finance/CFO | - |
SHIN-ETSU CHEMICAL CO., LTD. | Corporate Officer/Principal | - |
UMN PHARMA INC. | Director of Finance/CFO | 01/08/2013 |
Training of Tatsuyoshi Hirano
University of Hitotsubashi | Undergraduate Degree |
The Johns Hopkins University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SHIN-ETSU CHEMICAL CO., LTD. | Process Industries |
Private companies | 3 |
---|---|
UMN Pharma, Inc.
UMN Pharma, Inc. Pharmaceuticals: MajorHealth Technology UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. | Health Technology |
Toys "R" Us-Japan Ltd.
Toys "R" Us-Japan Ltd. Specialty StoresRetail Trade Toys "R" Us-Japan Ltd. operates a chain of toy and juvenile products retail stores. Its products include educational toys, dolls, plush toys and character toys, video games, bicycles, sporting goods, stationery, baby clothing, shoes, strollers, car seats, food and formula. The company was founded on November 21, 1989 and is headquartered in Kawasaki, Japan. | Retail Trade |
UNIGEN Inc.
UNIGEN Inc. Pharmaceuticals: MajorHealth Technology UNIGEN Inc. engages in the contract manufacturing of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, rotavirus and others. The company was founded on May 18, 2010 and is headquartered in Akita, Japan. | Health Technology |
- Stock Market
- Insiders
- Tatsuyoshi Hirano